Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International clarify registry
Background: Few data are available regarding the use of antithrombotic strategies in coronary artery disease patients with atrial fibrillation (AF) in everyday practice. We sought to describe the prevalence of AF and its antithrombotic management in a contemporary population of patients with stable...
Elmentve itt :
Szerzők: |
Fauchier Laurent Greenlaw Nicola Ferrari Roberto Ford Ian Fox Kim M. Tardif Jean-Claude Tendera Michal Steg Gabriel Ph CLARIFY Investigators Jánosi András Forster Tamás Merkely Béla Péter |
---|---|
Dokumentumtípus: | Cikk |
Megjelent: |
2015
|
Sorozat: | PLOS ONE
10 No. 4 |
doi: | 10.1371/journal.pone.0125164 |
mtmt: | 3130766 |
Online Access: | http://publicatio.bibl.u-szeged.hu/18026 |
Hasonló tételek
-
Patients' knowledge on oral anticoagulant treatment in Hungary
Szerző: Viola Réka, et al.
Megjelent: (2017) -
Outcomes of uninterrupted vs interrupted Periprocedural direct oral Anticoagulants in atrial Fibrillation ablation A meta-analysis /
Szerző: Basu-Ray Indranill, et al.
Megjelent: (2021) -
CJEU clarifies that framing infringes copyright if TPMs are circumvented
Szerző: Mezei Péter, et al.
Megjelent: (2021) -
Effect of enzymes and clarifying agents on quality parameters of elderberry juice
Szerző: Szalóki-Dorkó Lilla, et al.
Megjelent: (2016) -
Minimally interrupted novel oral anticoagulant versus uninterrupted vitamin K antagonist during atrial fibrillation ablation
Szerző: De Heide John, et al.
Megjelent: (2018)